Chad Bousman
Cited by
Cited by
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, ...
Molecular psychiatry 23 (5), 1261-1269, 2018
Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials
CA Bousman, K Arandjelovic, SG Mancuso, HA Eyre, BW Dunlop
Pharmacogenomics 20 (01), 37-47, 2019
Accelerated gray and white matter deterioration with age in schizophrenia
VL Cropley, P Klauser, RK Lenroot, J Bruggemann, S Sundram, ...
American Journal of Psychiatry 174 (3), 286-295, 2017
Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study
J Sarris, C Stough, CA Bousman, ZT Wahid, G Murray, R Teschke, ...
Journal of clinical psychopharmacology 33 (5), 643-648, 2013
An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels
J De Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ...
Pharmacopsychiatry 55 (02), 73-86, 2022
Commercial pharmacogenetic-based decision-support tools in psychiatry
CA Bousman, M Hopwood
The Lancet Psychiatry 3 (6), 585-590, 2016
Review and consensus on pharmacogenomic testing in psychiatry
CA Bousman, SA Bengesser, KJ Aitchison, AT Amare, H Aschauer, ...
Pharmacopsychiatry 54 (01), 5-17, 2021
White matter disruptions in schizophrenia are spatially widespread and topologically converge on brain network hubs
P Klauser, ST Baker, VL Cropley, C Bousman, A Fornito, L Cocchi, ...
Schizophrenia bulletin 43 (2), 425-435, 2017
Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples
CA Bousman, G Chana, SJ Glatt, SD Chandler, GR Lucero, E Tatro, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010
Predictors of substance use among homeless youth in San Diego
CA Bousman, EJ Blumberg, AM Shillington, MF Hovell, M Ji, S Lehman, ...
Addictive behaviors 30 (6), 1100-1110, 2005
Evidence for network-based cortical thickness reductions in schizophrenia
CMJ Wannan, VL Cropley, MM Chakravarty, C Bousman, EP Ganella, ...
American Journal of Psychiatry 176 (7), 552-563, 2019
Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools
CA Bousman, BW Dunlop
The pharmacogenomics journal 18 (5), 613-622, 2018
Systematic review and critical appraisal of child abuse measurement instruments
SM Saini, CR Hoffmann, C Pantelis, IP Everall, CA Bousman
Psychiatry research 272, 106-113, 2019
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
AB Singh, CA Bousman, CH Ng, K Byron, M Berk
Translational psychiatry 2 (11), e198-e198, 2012
Individual deviations from normative models of brain structure in a large cross-sectional schizophrenia cohort
J Lv, M Di Biase, RFH Cash, L Cocchi, VL Cropley, P Klauser, Y Tian, ...
Molecular psychiatry 26 (7), 3512-3523, 2021
Genetic association studies of methamphetamine use disorders: a systematic review and synthesis
CA Bousman, SJ Glatt, IP Everall, MT Tsuang
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150 …, 2009
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin …
CA Bousman, JM Stevenson, LB Ramsey, K Sangkuhl, JK Hicks, ...
Clinical Pharmacology & Therapeutics 114 (1), 51-68, 2023
Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
CA Bousman, M Forbes, M Jayaram, H Eyre, CF Reynolds, M Berk, ...
BMC psychiatry 17, 1-7, 2017
Early origins of mental disorder-risk factors in the perinatal and infant period
L Newman, F Judd, CA Olsson, D Castle, C Bousman, P Sheehan, ...
BMC psychiatry 16, 1-8, 2016
Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel
C Bousman, A Al Maruf, DJ Müller
Current opinion in psychiatry 32 (1), 7-15, 2019
The system can't perform the operation now. Try again later.
Articles 1–20